Elekta AB - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Elekta AB Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Elekta AB. The Group's principal activities are supplying systems and offering clinical solutions for effective treatment of severe diseases including cancer, vascular disorders in the brain, and diseases of the central nervous system such as Parkinson's disease and epilepsy. The Group's products include Leksell Gamma Knife, Neuromag Vectorview, Brain Atlas, Leksell Stereotactic System and PreciseSIM. The principal markets for the Group's products are Europe, North America, Japan and the rest of Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report